In a pioneering clinical trial, the ReNeuron Group has announced that the first patient to be treated with the company’s ReN001 stem cell therapy for stroke has been safely discharged from the Institute of Neurological Sciences at Southern General Hospital in Glasgow.
ReNeuron is the first company to have received regulatory approval for any stem cell-based clinical trial in the UK.